Prior to joining Francisco Partners in 2008, Chris worked at American Securities Capital Partners, where he evaluated and executed private equity transactions in a variety of industries including energy, defense, and industrial technology. Chris previously worked as a strategy consultant in the Atlanta, Sao Paulo, and Sydney offices of Bain & Company. He has also worked for a venture capital firm in Bangalore and a technology startup in Shanghai.
Chris currently serves on the board of directors of NexTraq, QuadraMed, Quantros, and Therapeutic Research